<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0480">
 <label>96</label>
 <element-citation publication-type="book" id="rf0470">
  <person-group person-group-type="author">
   <name>
    <surname>Xu</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Han</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Sun</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Fu</surname>
    <given-names>B.</given-names>
   </name>
  </person-group>
  <chapter-title>Effective treatment os severe COVID-19 patients with tocilizumab</chapter-title>
  <source>ChinaXiv:20200300026</source>
  <year>2020</year>
 </element-citation>
</ref>
